Anzeige
Mehr »
Login
Freitag, 26.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Geheimtipp: Rasanter Aufstieg, Branchenrevolution und Jahresumsatz von 50 Mio. $
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
63 Leser
Artikel bewerten:
(0)

Two Day Annual Drug Repositioning, Repurposing and Rescue Conference - Industry Registration (Chicago, United States - June 27-28, 2017) - Research and Markets

DUBLIN, May 19, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "The 6th Annual Drug Repositioning, Repurposing and Rescue Conference - Industry" conference to their offering.

Research and Markets Logo

Join us in Chicago, where we will highlight the latest developments in the fields of drug repositioning, repurposing and rescue. This conference continues to serve as a global meeting place for those engaged in efforts to further drug development through new means of collaborations, including patient advocacy efforts and industry/academic/government cooperation.

A central focus at this year's event will be the use of repurposing to find and develop new therapies for rare diseases. Many rare diseases and disorders are serious conditions with no approved treatments. There is thus significant unmet needs for patients. The pharmaceutical industry has become engaged in a greater effort to develop drugs for these "orphan" indications. The FDA has supported this effort via various special protocols as well. There is a growing amount of evidence which suggests repurposing or repositioning research can greatly aid in the development of drugs for rare diseases. By using a more systematic approach, existing compounds are being tested for both common and neglected diseases faster and with more success.

Key Themes at This Year's Conference

PATIENT ADVOCACY EFFORTS
Emphasis on and engagement with patient advocacy groups, who are investing in drug repositioning efforts to an unprecedented degree

NEW PARTNERSHIPS
The conference will explore how new partnerships between various groups, including government, industry and academia are teaming up to advance repurposing efforts

COMMERCIAL CASE STUDIES
Leaders in drug repositioning will discuss their successes, failures and the way forward

COLLABORATIVE EFFORTS
Government/Academic/Industry Collaborations will be explored and highlighted in order to determine how disparate groups can achieve success

SYSTEMATIC REPOSITIONING AND DATA ANALYTICS
Repurposing is no longer based on serendipity as more and more companies are designing tools to streamline and increase the odds of success

For more information about this conference visit http://www.researchandmarkets.com/research/x5jjlr/the_6th_annual


Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.